Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
N/A
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$4.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
Market Cap
$3.90M
Operating Margin
-774.90%
TTM Avg
-1185.31%
3Y Avg
-1296.90%
5Y Avg
-883.94%
Market Cap
$4.23M
Operating Margin
-162.87%
TTM Avg
-242.97%
3Y Avg
-229.35%
5Y Avg
-164.06%
Market Cap
$4.30M
Operating Margin
-484.31%
TTM Avg
-1917.01%
3Y Avg
-2405.16%
5Y Avg
-1618.57%
Market Cap
$3.79M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.72M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$4.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.13M | N/A | 0.00% | 0.00% | 0.00% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | 0.00% | 0.00% | -229.94% | -288.65% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -774.90% | -1185.31% | -1296.90% | -883.94% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.23M | -162.87% | -242.97% | -229.35% | -164.06% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.30M | -484.31% | -1917.01% | -2405.16% | -1618.57% |
| Evogene Ltd. (EVGN)vs › | $3.79M | -364.24% | -350.71% | -763.84% | -1461.60% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.72M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.64M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | -1160.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
